Hongchang International Co., Ltd (HCIL) stock: key figures, P/E, revenue and dividend
Health Care · ISIN US42831T2024
Price
0.00 USD
Market cap
155,649.41 USD
P/E (2025)
–
P/S (2025)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–
Hongchang International Co., Ltd financials
| Fiscal year | 2024 |
|---|---|
| Revenue | 2.87 m USD |
| Gross profit | 181,632.00 USD |
| Operating income | -383,326.00 USD |
| EBIT | -495,851.00 USD |
| Net income | -472,393.00 USD |
| Diluted EPS – continuing operations | 0.00 USD |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Hongchang International Co., Ltd
Hongchang International Co., Ltd engages in the food trading and biotechnology businesses in China, the United States, and internationally. It offers technical and consultation services. The company is based in Fuzhou, China.
More stocks
- 1847 Holdings LLC (LBRA)
- Mobile Global Esports, Inc. (MGAM)
- TRAFALGAR INTERNATIONAL, INC. (GCAN)
- CNBX Pharmaceuticals Inc. (CNBX)
- Nauticus Robotics, Inc. (KITT)
- ProPhase Labs, Inc. (PRPH)
- Digital Brands Group, Inc. (DBGI)
- Sigyn Therapeutics, Inc. (SIGY)
- First Choice Healthcare Solutions, Inc. (FCHS)
- Data443 Risk Mitigation, Inc. (ATDS)
- MEDIGENE N (MDG1.SG) (MDG1.SG)
- Petros Pharmaceuticals, Inc. (PTPI)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.